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Desmosomes are intercellular junctions of epithelia and cardiac muscle. They resist mechanical stress because they adopt a strongly adhesive
state in which they are said to be hyper-adhesive and which distinguishes them from other intercellular junctions; desmosomes are specialised for
strong adhesion and their failure can result in diseases of the skin and heart. They are also dynamic structures whose adhesiveness can switch
between high and low affinity adhesive states during processes such as embryonic development and wound healing, the switching being signalled
by protein kinase C. Desmosomes may also act as signalling centres, regulating the availability of signalling molecules and thereby participating in
fundamental processes such as cell proliferation, differentiation and morphogenesis. Here we consider the structure, composition and function of
desmosomes, and their role in embryonic development and disease.
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Desmosomes are intercellular junctions that provide strong
adhesion between cells. Because they also link intracellularly to
the intermediate filament cytoskeleton they form the adhesive
bonds in a network that gives mechanical strength to tissues.
Thus desmosomes are particularly abundant in tissues such as
epidermis and myocardium that are continually assailed by
mechanical forces. When desmosomal adhesion fails, as in
certain genetic and autoimmune diseases, tissues that are
subjected to mechanical stress may fall apart. The desmosome–
intermediate filament complex (DIFC) is a network or scaf-
folding that maintains the integrity of such tissues.
1.1. The strength of the desmosome–intermediate filament
complex
In any structure strength is dependent upon the strength of its
individual components. Thus there is no use having strong
scaffolding poles if the scaffold couplings are weak, and a chain
is only as strong as its weakest link. The DIFC may be dividedFig. 1. The desmosome-intermediate filament complex showing some of the key l
proteins within the outer dense plaque (ODP) is not fully understood, and plakoglobin
desmosomal cadherins. Alternatively desmoplakin may interact with the desmos
interactions (see text). PM, plasma membrane.into three components, two intracellular and one intercellular.
Intracellularly there are the intermediate filaments, and the
linkage between the intermediate filaments and the desmosomal
adhesion molecules; intercellularly there is the adhesive bond
provided by the desmosomal adhesion molecules (Fig. 1). The
two intracellular components of the DIFC have been much
studied but little is known about the mechanism of adhesive
binding.
Each of these three components of the DIFC must be equally
capable of resisting mechanical disruption and failure of any of
them is disastrous as illustrated by certain human diseases of the
epidermis (Fig. 1). Failure of the intermediate filaments is found
in epidermolysis bullosa simplex, an epidermal blistering dis-
ease of varying severity caused by mutations in the genes
encoding the basal epidermal keratins 5 and 14 [1]. These mu-
tations cause disruption of the keratin filaments and consequent
stress-induced rupture of basal epidermal cells. The linkage
between the intermediate filaments and the desmosomal
adhesion molecules is mediated by desmoplakin and the
armadillo proteins plakoglobin and plakophilin. Failure in one
part of this link is seen in the only case so far reported of lethalinks and diseases that weaken them. The interactions between the complex of
(not shown) may contribute to the link in the chain between desmoplakin and the
omal cadherins directly, with plakophilin and plakoglobin mediating lateral
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deletion of the C-terminus of desmoplakin resulted in de-
tachment of the keratin filaments and severe disruption of the
epidermis during birth. Failure in another part is shown by the
genetic disease ectodermal dysplasia/skin fragility syndrome, in
which plakophilin-1 mutations cause detachment of intermedi-
ate filaments and desmoplakin from the desmosome [3]. Failure
of desmosomal adhesive binding resulting in separation of
desmosomal halves in the intercellular region and consequent
epidermal blistering is seen in pemphigus in which the des-
mosomal cadherins desmoglein (Dsg) 1 and 3 are targeted by
autoantibodies [4].
1.2. Desmosomes resist mechanical stress because they are
hyper-adhesive
It has recently become clear how desmosomal adhesiveness
contributes to the strength of the DIFC. Desmosomes are able to
adopt two alternative adhesive states that differ in adhesive
affinity [5–7]. We refer to the more strongly adhesive des-
mosomes as “hyper-adhesive” to distinguish this state from the
weaker condition. Hyper-adhesiveness is characterised experi-
mentally by calcium independence, that is resistance of desmo-
somes to disruption by chelating agents. This is very surprising
because the desmosomal adhesion molecules, desmocollin and
desmoglein, are members of the cadherin family of calcium
dependent adhesion molecules. Using calcium independence as
a criterion we have shown hyper-adhesion to be the normal
adhesive state of tissue desmosomes, which are therefore strong-
ly adhesive and able to resist disruption by mechanical forces.
More weakly adhesive desmosomes are calcium dependent; that
is their adhesion may be disrupted by depletion of extracellular
calcium resulting in separation of half desmosomes in the
intercellular plane. In this condition desmosomal adhesiveness
resembles that of adherens junctions, the other major adhesive
junctional type, which as far as we can tell are not able to become
hyper-adhesive. Hyper-adhesiveness may therefore be regarded
as a property unique to desmosomes and the reason why they are
able to provide a strong link in the DIFC chain.
1.3. Hyper-adhesiveness can be modulated by intracellular
signalling
The linking of cells by strong adhesion is fine for resisting
mechanical stress but would seem incompatible with cell moti-
lity. During epidermal wound repair keratinocytes form a single
layer from the multilayered epidermis and are so able to migrate
under the clot and close the wound. Conversion to a single layer
inevitably involves down-regulation of desmosomal adhesion.
We have shown that desmosomes in wound edge epidermis are
calcium dependent and thus have lost the hyper-adhesiveness
characteristic of most, possibly all, desmosomes in normal,
unwounded epidermis [6]. This result was the in vivo correlate of
observations previously made with MDCK cells in culture [5].
Sub-confluent cells never acquired calcium independent desmo-
somes but once confluent nearly 100% of cells became calcium
independent over a period of days. If confluence was thendestroyed by scratch wounding cells at the wound edge rapidly
reverted to calcium dependence, an effect that was propagated
into the monolayer. We showed that switching from calcium
dependence to independence could be rapidly achieved (in
minutes) by inhibiting conventional isoforms of protein kinase C
(PKC) and the reverse switch by PKC activation [5]. In MDCK
cells PKC alpha was the isoform involved. In wound edge epi-
dermis, PCK alpha became associated with desmosomal plaques
[6].
In a recent study with the human keratinocyte cell line
HaCaT, we showed that neither slow acquisition of calcium
independence by confluent cells nor rapid switching between
the alternative states with a PKC activator or inhibitor involved
any change, qualitative or quantitative, in the composition of
desmosomes [7]. This accorded with previous observations that
switching could be achieved in the absence of protein synthesis
[5]. These results indicate that the change is produced by gen-
eration of an “inside-out” signal by PKC.
1.4. Desmosome structure—can it account for hyper-adhesion?
Desmosomes have a quite characteristic highly organised,
electron dense structure. They are less than 1 μm in diameter
and consist of a central core region that spans the intercellular
space between apposing cells and separates two identical
cytoplasmic plaques that are associated with the intermediate
filament network (Fig. 2). It seems very likely that this unique,
robust-looking structure holds the key to understanding the
basis of hyper-adhesiveness.
The intercellular space has been variously reported as bet-
ween 20 and 35 nm wide. The most recent study by cryo-
electron microscopy of rapidly frozen material indicates that it
is about 34 nm [8]. By conventional transmission electron mi-
croscopy it is characterised by the presence of a dense midline
with cross-bridges extending to the plasma membrane. We
believe that the midline is indicative of a highly organised
arrangement of the extracellular domains of the desmosomal
cadherins that is crucial for calcium-independence and hyper-
adhesiveness because it is present in the desmosomes of normal
epidermis but absent from desmosomes of wound edge
epidermis that have lost hyper-adhesiveness to become calcium
dependent [6].
Rayns et al. [9] infiltrated the extracellular space of desmo-
somes with the electron-dense tracer lanthanum and found two
important results. Firstly, the cross-bridges extending to the
plasma membrane appear to alternate on opposite sides of the
midline. Secondly, as well as being ordered in the z-plane, the
desmosomal cadherin extracellular domains appear to be
ordered in the x-, y-plane. The lanthanum-filled spaces appeared
as a pattern of black dots, described as a quadratic array, with a
repeat period of 75 Å. We have described this arrangement as
quasi-crystalline and have shown by homology modelling of
the desmosomal cadherins on the crystal structure of XenopusC-
cadherin described by Boggon et al. [10] that such a structure
provides a very reasonable model of the desmosomal intercel-
lular material in the x-, y- and z-planes, with a periodicity,
coincidentally or not, of approximately 75 Å [6].
Fig. 2. (A) Appearance of a desmosome at the ultrastructural level. PM, plasma membrane; ICS, intercellular space; ODP, outer dense plaque; IDP, inner dense plaque;
IFs, intermediate filaments. Bar, 0.1 μm. (B) Visualisation of desmosomes in mouse epidermis by immuno-staining with an antibody against desmoplakin. SC, stratum
corneum; HF, hair follicle. Bar, 25 μm. (C) Expression pattern of desmosomal constituents in the epidermis. Dsc, desmocollin; Dsg, desmoglein; PG, plakoglobin;
PKP, plakophilin; DP, desmoplakin. (D) Skin from a patient with pemphigus foliaceus showing a blister in the superficial epidermis. (E) Skin from a patient with the
mucocutaneous form of pemphigus vulgaris showing a blister just above the basal cell layer. Panels D and E are reproduced from reference [132] with permission.
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suggested a rather looser arrangement of the desmosomal cad-
herin extracellular domains involving the presence of trimers
that form what are described as knots [11]. It is difficult to see
how this type of loose arrangement can account for the calcium
independence and hyper-adhesiveness of desmosomes, and the
transition to calcium dependence. Both the model of He et al.
[11] and our own are based on the crystal structure of C-
cadherin in which the extracellular domains are curved [10].
The cryo-electron microscopy study referred to above suggests
that they are straight [8]. The curvature in the crystal structure
permits both trans and cis interactions between the cadherin
molecules and we have speculated that the latter may be crucial
in relation to calcium independence [6].
Calcium independence may arise because one or more
calcium ions is/are trapped within the structure. Such a sug-
gestion is not unprecedented because a trapped, EGTA-
resistant calcium ion participates in the formation of the
actin–gelsolin complex [12,13]. In the cadherin crystal struc-
ture a small β-helix involved in the cis interactions shields one
of the bound calcium ions, which may therefore be resistant to
removal by chelating agents [6]. We propose that transition to
calcium dependence involves a loss of order among the extra-
cellular domains due to loss of cis interactions (trans inter-
actions must be maintained because adhesion is not lost) and
exposure of the trapped calcium ion. (If calcium is indeed
trapped in hyper-adhesive desmosomes it would be inaccurate
to call them “calcium independent”; “EGTA resistant” would
be better. Calcium independence should be regarded as an
operational term applied to the experimental demonstration of
hyper-adhesiveness.)The desmosomal cadherins are transmembrane proteins with
their cytoplasmic domains residing in the desmosomal plaque.
It would therefore seem that order in the intercellular space
needs to be matched by order in the plaque. Even less is known
about the structure of the plaque than of the intercellular
material. It consists of two densities, a very dense outer dense
plaque (ODP) that is about 20 nm thick and close to the inner
leaflet of the plasma membrane and a narrower and less dense
inner dense plaque that is located where the intermediate
filaments attach. The two densities are separated by a less dense
region and the thickness of the whole is about 40 nm. There is
evidence of highly ordered structure in the plaque. Both Miller
et al. [14] and North et al. [15] noted a transverse periodicity in
the ODP, stated by the former to have a repeat period of 2.6 nm.
North et al. [15] used quantification of immunogold labelling
of ultrathin cryo-sections with domain-specific antibodies to
construct a low resolution molecular map of the desmosomal
plaque. This indicates an ordered arrangement of desmosomal
components in the z-dimension. It seems equally likely that
there is an ordered arrangement in the x-, y-plane but no
attempts have been made to confirm this.
In summary, it is our hypothesis that molecular order in the
plaque corresponds to and generates order of the desmosomal
cadherin extracellular domains. Once so ordered the extracel-
lular domains are locked into a hyper-adhesive configuration.
This involves trapping of calcium within one or more of the
extracellular calcium binding domains. Organisation in the
plaque can be altered by phosphorylation of plaque proteins by
PKC and perhaps other kinases. We suggest that the addition of
large negatively charged phosphate groups disturbs the packing
of the molecules within the plaque. When this happens the ex-
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desmosomal cadherins bind with lower affinity and calcium is
readily removed by chelating agents. The affinity of binding by
individual pairs of classical cadherins is very low [16] and there
is no reason to suppose that desmosomal cadherins bind more
tightly. Instead desmosomes have developed a type of mo-
lecular locking mechanism that locks the whole desmosome
into a hyper-adhesive state while at the same time remaining
flexible and reversible.
1.5. Significance of hyper-adhesion for embryonic development
and the experimental approach to epithelial cell behaviour
During embryogenesis tissues need to remain flexible and
malleable in terms of cell motility until their development is well
advanced; they must not be immobilised by their intercellular
contacts. Desmosomal components are expressed very early in
some developing organs, for example the kidney tubules, but the
morphology of early desmosomes appears rudimentary [17]. We
have now shown that desmosomes in developing epidermis of
the mouse embryo change from calcium dependent to calcium
independent between days 12 and 14 of development and PKC
appears to be involved in maintaining their calcium dependence
at the early stages (Kimura, T.E., Merritt, A.J. and Garrod, D.R.,
unpublished data). Thus desmosomal hyper-adhesiveness is
developmentally regulated in the epidermis. A similar situation
is to be anticipated in other developing organs but this has not yet
been tested.
Where epithelial barrier function is being tested care is
always taken to grow the cells to confluence. However, many
other experiments in tissue culture are carried out on sub-
confluent epithelial cells. It should be cautioned that such cells
are in a thoroughly abnormal context. Epithelial cells in vivo are
always in confluent cell sheets. As far as we can tell the vast
majority of such cells have hyper-adhesive desmosomes but
sub-confluent cells in culture do not [5,6]. There are certainly
many other ways in which confluent and sub-confluent epi-
thelial cells differ from each other. In the context of cell
adhesion this seems particularly relevant in relation to studies
on cell proliferation, cell motility and epithelial–mesenchymal
transition, and junction disassembly.
2. Desmosome composition
In the DIFC (Fig. 1) desmoplakin acts as a linker between
intermediate filament scaffolding and the desmosomal plaque.
Desmosomal cadherins span the membrane with their C-
terminal domains localised in the plaque and their N-terminal
domains coupling the two halves of the desmosome together in
the intercellular space. A complex of proteins is found within
the plaque region, the interactions between which are not yet
fully understood. The proteins involved include plakoglobin
and plakophilins, members of the armadillo family. Thus, in so
far as is known, all desmosomes contain desmoplakin, plako-
globin and at least one isoform each of plakophilin and the
desmosomal cadherins desmocollin and desmoglein. A number
of other ‘accessory’ proteins are associated with desmosomes.Some accessory proteins are essential for adhesive function, but
only in a subset of tissues, whereas others are not vital for
adhesion. Proteins in the former category include Perp and
corneodesmosin whereas the armadillo protein p0071 falls into
the latter [18–20].
2.1. Desmoplakin
Desmoplakin is essential for normal desmosomal adhesion.
It interacts with keratin intermediate filaments in epithelial cells,
desmin intermediate filaments in cardiomyocytes and vimentin
intermediate filaments in arachnoid and follicular dendritic
cells. Desmoplakin's structure is tripartite in nature with glo-
bular head and tail domains flanking a coiled-coil rod region
(Fig. 3). This central rod region is thought to allow dimerisation
of desmoplakin molecules. The globular head, or plakin do-
main, is an important region for protein–protein interactions,
and the latest evidence suggests that it consists of two pairs of
spectrin repeats separated by a Src-homology-3 domain [21].
The C-terminal tail domain consists of three plakin repeat
domains (PRDs) designated A, B and C. Each of these comprise
4.5 copies of a 38 amino acid motif. Domains B and C, which
share 29% sequence identity, are globular structures and each
features a groove that could represent an intermediate filament
binding site [22]. At the extreme C-terminus of desmoplakin is a
glycine–serine–arginine rich domain; phosphorylation of serine
residue in this domain could regulate the ability of desmoplakin
to interact with intermediate filaments [23]. There are two iso-
forms of desmoplakin (DPI and DPII) that are generated by
alternative splicing and differ only in the length of the central
rod domain. It appears that DPI and DPII are to some extent
functionally redundant. Loss of the C-terminal tail domain from
DPI/DPII has devastating consequences on skin integrity and
results in early neonatal death in lethal acantholytic epidermo-
lysis bullosa [3]. By contrast a human patient who showed loss
of DPI but retained expression of DPII survived until early
childhood [24].
Until recently desmoplakin was thought to interact exclu-
sively with the intermediate filament cytoskeleton. However,
recent experiments have shown that it may also be involved in
regulating microtubule organisation. As keratinocytes differen-
tiate their cytoskeleton undergoes a rearrangement from a net-
work that extends throughout the cell and emanates from the
centrosome to one that is restricted to the cell periphery and is
concentrated at desmosomes. It now appears that desmoplakin-
dependant recruitment of the microtubule anchoring protein
ninein is essential for this process [25].
2.2. Armadillo proteins
Armadillo family members are characterised by the presence
of a central domain containing a variable number of imperfect 42
amino acid repeats (arm repeats). Armadillo proteins found in
desmosomes include plakoglobin (γ-catenin) and the plakophi-
lins, of which there are three (PKP1–3). Plakoglobin contains 12
arm repeats (Fig. 3). It exhibits dual localisation in desmosomes
and adherens junctions, where it is interchangeable with the
Fig. 3. Structure of desmosomal proteins. (A) Desmoplakin. The two desmoplakin isoforms are shown. A, B and C are plakin repeat domains. GSR, glycine–serine–
arginine rich domain. (B) Armadillo proteins. Plakoglobin (PG) contains 12 arm repeats whereas the plakophilins have 9 with an insert between repeats 5 and 6
(hatched box) that introduces a bend into the overall structure. The two known isoforms of PKP2 are shown. (C) Desmosomal cadherins. All desmosomal cadherins, of
which Dsc2 and Dsg2 are shown, are synthesised with N-terminal signal and pro-peptides (not shown) that are cleaved during protein maturation. The cell adhesion
recognition (CAR) site contributes to the adhesive function of desmosomal cadherins. Desmocollin ‘a’ proteins and desmoglein cytoplasmic regions contain an
intracellular cadherin-like sequence (ICS) domain. A truncated version of this domain, together with a number of unique amino acids (11 in human Dsc2b, hatched
box), are found in desmocollin ‘b’ proteins. EC1–4, extracellular cadherin repeats; EA, extracellular anchor; TM, transmembrane; IA, intracellular anchor; ICS,
intracellular cadherin-like sequence; IPL, intracellular proline-rich linker; RUD, repeat unit domain; DTD, desmoglein terminal domain. Note that the diagram is not
drawn to scale.
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plakoglobin appears to be localised in desmosomes, probably
because its affinity for desmosomal cadherins is several times
greater than that for E-cadherin [26]. There is evidence to sug-
gest that plakoglobin may be somehow involved in regulating
lateral association between other desmosomal components and
desmosome size. Thus deletion of the C-terminus of plakoglobin
led to formation of large desmosomes by lateral association in
cultured cells [27]. Deletion of plakoglobin in mice led to
intermixing of desmosomal and adherens junction proteins in
cardiac muscle and it may be that plakoglobin is also important
in regulating cross-talk between desmosomes and adherens
junctions [28,29]. As well as having a structural role in cell–cell
junctions plakoglobin participates in intracellular signal trans-
duction (see below).
Plakophilins 1–3 show complex tissue-specific patterns of
expression [30], and all three are expressed in the epidermis
where they exhibit differentiation-specific patterns of expression
(Fig. 2). All plakophilins contain 9 arm repeats with a flexible
insert between repeats 5 and 6 that introduces a major bend in the
overall structure [31]. There are two isoforms of plakophilins 1
and 2, a shorter ‘a’ variant and a longer ‘b’ form, generated by
alternative splicing. PKP1a and 1b differ by the insertion of 21amino acids between arm repeats 3 and 4 [32] whereas PKP2a
and 2b differ by the insertion of 44 amino acids between repeats
2 and 3 [33] (Fig. 3). Only one product of the PKP3 gene has
been described. All three plakophilins exhibit dual localisation
in desmosomes and the nucleus. PKP1b shows an exclusively
nuclear localisation [32] so it may be that additional amino acids
in the longer ‘b’ form are responsible for targeting it to the
nucleus. Intracellular localisation of plakophilins may also be
influenced by 14-3-3 proteins. The latter are abundant, widely
expressed proteins that bind to mainly phosphoserine motifs on
target proteins and in so doing modulate the behaviour of the
target [34]. Phosphorylation of PKP2 at serine residue 82 by
Cdc25C-associated kinase 1 (C-TAK1) creates a 14-3-3 binding
site [35]. When transfected into SCC-9 keratinocytes wild-type
PKP2 is mainly located at the plasma membrane. By contrast,
serine 82 PKP2 mutants that cannot bind 14-3-3 are predom-
inantly found in the nucleus [35]. The extra-junctional function
of plakophilins is a matter of some speculation. Plakophilins
have been associated with RNA polymerase III [36] and RNA
binding proteins [37] but the significance of these observations
is not clear.
p0071 is sometimes called plakophilin 4 but it is more closely
related to the adherens junction protein p120-catenin than it is to
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other proteins form one subgroup of the p120-catenin family
(itself a subgroup of the armadillo family) and plakophilins 1–3
form another distinct subgroup [38]. Whereas the presence of
plakoglobin and one of the three plakophilins is essential for
normal desmosomal adhesion, p0071 is generally considered to
be an accessory component [20]. Splice variants of p0071 have
been identified although their function is unknown [20]. Like
plakoglobin, p0071 exhibits dual localisation in desmosomes
and adherens junctions and could be involved in mediating
cross-talk between the two [39]. In contrast to the plakophilins it
is not normally found in the nucleus. A cytoplasmic pool of
p0071 has been detected and this may play an important role in
cell signalling [40] (and see below).
2.3. Desmosomal cadherins
The desmosomal cadherins are the membrane spanning
constituents of desmosomes (Fig. 3). In humans there are seven
desmosomal cadherins, three desmocollins (Dsc1–3) and four
desmogleins (Dsg1–4). Each of the three desmocollin genes
encodes a pair of proteins that are generated by alternative
splicing, a longer ‘a’ form and a shorter ‘b’ form that differ only
in the length of their C-terminal tails (Fig. 3). The desmocollin
extracellular domains can divided into a number of subdomains,
four cadherin-like EC domains and an extracellular anchor (EA)
domain. Desmoglein extracellular domains are organised in a
similar fashion (Fig. 3). Within the cell, both desmocollin ‘a’ and
‘b’ proteins possess an intracellular anchor (IA) domain but only
‘a’ form proteins have an intracellular cadherin-like sequence
(ICS) domain. Desmoglein cytoplasmic tails also have IA and
ICS domains. Desmocollin and desmoglein ICS domains
provide binding sites for other desmosomal constituents such
as plakoglobin (see below). Additional domains found in des-
moglein cytoplasmic tails include the intracellular proline-rich
linker (IPL) domain, a repeat unit domain (RUD) and a glycine-
rich desmoglein terminal domain (DTD). RUDs are made up of a
variable number of 29 amino acid repeating units; theDsg1RUD
contains 5 such repeating units whereas Dsg2, Dsg3 and Dsg4
have 6, 2 and 3 respectively. The function of the desmoglein-
specific cytoplasmic region (i.e. IPL domain, RUD and DTD) is
not known. Four of five repeats in the human Dsg1 RUD contain
a strong potential PKC phosphorylation site (TER) that is con-
served in cow, mouse and dog. The fifth repeat contains another,
albeit weaker, conserved potential site (TES). Putative PKC sites
are found in the RUD repeats in all four desmogleins and it is
conceivable that phosphorylation within the RUD, followed by a
conformational change, could transmit a signal to the extracel-
lular space and unlock the desmosome hyper-adhesive confor-
mation during wound healing [6,7]. PEST motifs are correlated
with rapid protein turnover [41] and Dsg1 has a potential PEST
sequence in the IPL domain. This, together with a caspase-3
cleavage site in the RUD [42], could contribute to dismantling of
desmosomes during processes such as apoptosis and desqua-
mation. Cleavage of the desmoglein extracellular domain by
metalloproteinases could also play a role in these processes
[42,43].The desmosomal cadherins exhibit tissue-specific patterns
of expression. Dsc2 and Dsg2 are expressed in all desmosome-
containing tissues whereas expression of the others is largely
restricted to stratified epithelial tissues. Hence, the desmo-
somes found in tissues such as colon and cardiac muscle con-
tain only Dsc2 and Dsg2. In epidermis, all seven desmosomal
cadherins are expressed in a differentiation-specific manner, the
‘2’ and ‘3’ proteins in the lower layers and the ‘1’ proteins and
Dsg4 in the upper layers (Fig. 2). Several different isoforms are
expressed in the same individual cells and single desmosomes
contain more than one desmocollin and more than one des-
moglein [44–46]. All desmosomal cadherin genes are located
in the same region of chromosome 18 [47] and it may be that
desmosomal cadherin gene expression is coordinated, at least
in part, by shared long-range genetic elements [48].
Why there should be multiple desmosomal cadherin isoforms
is a major puzzle. It may be that they have different adhesive
properties that are required at different levels in stratified epithe-
lia or that they have specific functions in epithelial differenti-
ation (see below). Our unpublished observations on the desmo-
somal cadherins of zebrafish reveal that they have only one
desmocollin, which is the homologue of mammalian Dsc1, and
two closely related desmogleins that differ only in the presence
or absence of a 40 amino acid insert in the extracellular domain
and that are closely related to mammalian Dsg2 (Luan, X.-M.,
Garrod, D.R. and Hurlstone, A., unpublished data). Zebrafish
form quite complex epithelia without a requirement for multiple
desmosomal cadherin isoforms.
2.4. Perp
Perp is a tetraspan membrane protein that is localised to the
desmosomes of stratified epithelia and heart [18,49]. Perp null
mice exhibit severe blistering of the skin and oral mucosa and
die soon after birth [18]. Desmosome morphology is abnormal
in these mice, and it would seem that Perp, although not
required in simple epithelia, is essential for normal desmosome
adhesive function in stratified tissues. Whether Perp is a bona
fide structural constituent of desmosomes in these tissues, or
plays an as yet unknown role in desmosome assembly, remains
to be determined.
2.5. Corneodesmosin
Corneodesmosin is a secreted glycoprotein that is incorpo-
rated into desmosomes prior to their conversion to corneodes-
mosomes in the cornified layers of the epidemis. During corneo-
desmosome formation the extracellular core of the desmosome is
transformed into a uniform electron-dense plug whereas the
intracellular plaque region is incorporated into the cornified
envelope, a specialised protective barrier that is assembled
directly beneath the plasma membrane. It is now thought that
corneodesmosin acts as an adhesion molecule [50] and that its
proteolytic degradation is a prerequisite for desquamation [51].
Premature proteolysis of corneodesmosin and associated des-
mosomal fragility may be important in Netherton syndrome [19]
(and see below). Conversely persistence of corneodesmosin-
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ses) and a variety of hyperkeratotic states including psoriasis.
Interestingly, PSORS1, a major psoriasis-susceptibility locus,
has been mapped to the region surrounding the corneodesmosin
gene [52]. Corneodesmosin is also expressed in the inner root
sheath of hair follicles, where it may or may not be associated
with desmosomes, and autosomal dominant mutations in cor-
neodesmosin cause hypotrichosis simplex of the scalp, a form of
alopecia in which affected individuals suffer from progressive
loss of scalp hair with onset in early childhood [53].
2.6. Interactions between desmosomal constituents
2.6.1. (a) Adhesive binding
Desmocollins and desmogleins are invariably co-expressed
in tissues that produce desmosomes and it is generally accepted
that both are required for desmosomal adhesion. However it
should be noted that one study by Koeser et al. [54] has come to
the somewhat surprising conclusion that a desmocollin is dis-
pensable for desmosome formation in a fibrosarcoma-derived
cell line. Expression of both a desmocollin and a desmoglein,
together with plakoglobin, in non-adhesive L929 fibroblasts
(which do not produce desmosomes) produces substantial
adhesion in aggregation assays [55,56] whereas in analogous
experiments expression of either desmosomal cadherin alone
produced at best only very weak homophilic adhesion [57,58].
These and other experiments [59] have led to the conclusion
that binding between desmosomal cadherins is predominantly
heterophilic. However, several more recent pieces of evidence
suggest that homophilic adhesion is also possible. Syed et al.
[60] found that recombinant extracellular domains of desmo-
somal cadherins could bind both heterophilically and homo-
philically, and Waschke et al. [61] showed by atomic force
microscopy that Dsg3 extracellular domains bind homophili-
cally. The observations of Koeser et al. [54] also imply homo-
philic adhesion by desmoglein, and Runswick et al. [62]
showed that inhibition of desmosome formation required anti-
adhesion peptides directed against both desmocollin and des-
moglein, an observation that is also consistent with homophilic
adhesion [62]. Significantly, the two last studies involved cells
that form desmosomes, whereas all previous observations were
made on either recombinant proteins or cells that do not form
desmosomes.
Given that desmosomes are highly specialised adhesive
structures it is crucial to determine how desmosomal cadherins
bind within them. In an as yet unpublished study we have used
membrane-impermeable homobifunctional cross-linking to
study adhesive binding by desmosomal cadherins in the
human keratinocyte cell line HaCaT (Nie, Z., Merritt, A.J. and
Garrod, D.R., unpublished data). These cells express Dsc2 and 3
and Dsg2 and 3, all of which are co-localised in the same
desmosomes. Cross-linking produced dimers that contained
only one desmosomal cadherin type. Further experiments indi-
cated that dimer formationwas cell–cell adhesion dependent and
occurred in trans, i.e. between molecules on apposed cell sur-
faces. This indicates that desmosomal cadherin adhesive binding
in desmosomes is homophilic and isoform-specific, a result thatmay have profound implications for desmosome structural orga-
nisation (Fig. 4).
Adhesive binding by classical cadherins involves the for-
mation of strand dimers in which N-terminal beta-strand
exchange takes place between the EC1 domains of cadherin
monomers on opposite cells [10]. This involves insertion of
the hydrophobic side chains of tryptophan residues in position
2 (Trp2) into hydrophobic pockets formed by other regions of
the EC1 domains. Trp2 and certain residues that participate in
the hydrophobic pocket, such as Ala80, are conserved in all
desmosomal cadherins and homology modelling shows that
desmosomal cadherins can be modelled on the crystal
structure of Xenopus C-cadherin with root-mean-square de-
viations for all equivalent carbon atoms of 1.03 Å for Dsc2
and 1.04 Å for Dsg2 [6]. Strand dimer formation therefore
represents a reasonable model for adhesive binding by des-
mosomal cadherins. Two pieces of experimental evidence are
consistent with this mode of adhesive interaction. Firstly,
adhesive binding by desmosomal cadherins can be inhibited
by peptides corresponding in sequence to the so-called cell
adhesion recognition (CAR) sites, which contribute to the
hydrophobic pockets [55,62]. Secondly, mutation of Trp2 and/
or Ala80 abolishes trans interaction by Dsg2 (Nie, Z., Merritt,
A.J. and Garrod, D.R., unpublished data). It therefore seems
reasonable to speculate that the mechanism of adhesive
binding by desmosomal cadherins resembles that of classical
cadherins.
2.6.2. (b) Intracellular binding
Intracellular interactions between desmosomal proteins are
described elsewhere [63,64] and will not be discussed in detail
here. Briefly, the general consensus is as follows. Desmogleins
and desmocollin ‘a’ proteins interact with distinct sites in the
central arm repeat domain of plakoglobin [65] through their ICS
domains [66,67] (Fig. 3). Plakoglobin also interacts with the N-
terminal plakin domain of desmoplakin [68]. The C-terminal
domain of desmoplakin interacts with intermediate filaments
[69,70] and so completes a chain of molecules that links the
membrane to the cytoskeleton (Fig. 4). In this chain plakoglobin
may act as a linker between the desmosomal cadherins and
desmoplakin, or it may be that the desmosomal cadherins
interact directly with desmoplakin [67,71] and that plakoglobin
is involved in regulating lateral interactions and desmosome size
(see above). Plakophilins interact with multiple partners (desmo-
somal cadherins, plakoglobin, desmoplakin and intermediate
filament proteins) and could also act as linkers or be involved in
lateral interactions [72]. A number of studies have suggested that
the head domain of plakophilins is sufficient for plasma mem-
brane localisation and is required for the subsequent recruitment
of desmoplakin [72,73]. More recent data indicate that C-
terminal residues may also be important for plasma membrane
localisation [74]. The role of the desmocollin ‘b’ proteins and
DPII in desmosome structure has not been determined although
it is now known that PKP3 interacts with desmocollin ‘b’ pro-
teins [75]. Studies on zebrafish show that zDsc1 lacks a ‘b’ form
so this alternatively spliced variant is not absolutely required for
desmosome formation, making its function even more myste-
Fig. 4. Schematic model of a desmosome showing the relative positions of the major desmosomal components. The scale on the right hand side indicates distance in
nanometres. The figure is largely based on the immuno-gold labelling experiments of North et al. [15].
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3. Desmosome function
The principle function of desmosomes is adhesion and
maintenance of tissue integrity. However, it is often not clear
whether the symptoms that occur in human diseases that target
desmosomes arise primarily from loss of adhesion or from
modulation of signalling pathways involving desmosomes.
Thus altered cell signals may themselves cause loss of desmo-
somal adhesion or indeed changes in tissue phenotype. In this
section we discuss how studies of such diseases together with
research on transgenic and knockout mice are raising awareness
of this dilemma.
3.1. Loss of desmosomal adhesion can disrupt tissue integrity
In pemphigus cell–cell adhesion is lost because desmosomal
halves separate in the intercellular region. There are two majortypes of pemphigus, pemphigus foliaceus (PF) and pemphigus
vulgaris (PV). PF is caused by pathogenic anti-Dsg1 auto-
antibodies in patients' sera and is characterised by blistering in
the superficial layers of the skin (Fig. 2). PV can be divided into
two sub-types, a mucosal-dominant type which presents with
oral lesions and little or no skin involvement, and a muco-
cutaneous type with both oral and skin lesions. The mucosal-
dominant form of PV is caused by anti-Dsg3 autoantibodies.
Patients with mucosal-dominant PV can acquire the mucocuta-
neous form of the disease, with blisters deep within the
epidermis (Fig. 2), if they go on to develop autoantibodies
against Dsg1. The desmoglein compensation theory (see [76])
has been developed to explain these findings. According to this
hypothesis blisters occur in the upper epidermis in PF because
autoantibodies interfere with the function of Dsg1 and Dsg3 is
not expressed at sufficient levels in upper layers to compensate
for its absence. In early, mucosal-dominant PV autoantibodies
against Dsg3 are insufficient to cause blistering in epidermis,
supposedly because Dsg1 expression in basal layers compen-
sates for lack of Dsg3 function. Blistering in the epidermis only
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against Dsg1. Many unanswered questions remain (see [77]).
For example it is not clear why Dsg4 is unable to compensate for
the loss of Dsg1 function in PF. Similarly it is not clear why loss
of adhesion invariably occurs between the basal and first
suprabasal cell layer in PVas one might expect the epidermis to
be weakened throughout. We have suggested that this may occur
because a plane of weakness exists at this level in the epidermis,
so a general weakening of adhesion causes the epidermis to split
at this, the weakest point [78].
Until recently it was generally accepted that pathogenic anti-
desmoglein antibodies interfered with desmoglein function by
steric interference and in so doing caused a subsequent loss of
intercellular adhesion. This explanation of disease pathogenesis
has a simple and straightforward beauty about it, but many
questions are now being asked about its validity [77]. It may be
that anti-desmoglein antibodies do not directly block interac-
tions between desmoglein molecules on adjacent cells. Using
single-molecule atomic force microscopy to investigate adhe-
sion between Dsg1 molecules Waschke et al. [61] have shown
that pemphigus foliaceus IgG from patients is unable to interfere
with Dsg1–Dsg1 binding. A considerable amount of evidence is
emerging to suggest that binding of autoantibodies to desmo-
gleins, or indeed to other molecules at the cell surface, triggers a
series of events that results in desmosome disassembly and
keratin filament retraction. These events could include desmo-
glein phosphorylation and its subsequent dissociation from
plakoglobin [79] and/or desmoglein endocytosis from the cell
surface in a complex with plakoglobin [80]. A mechanism that
adequately explains how pemphigus IgG can trigger such events
has yet to be proposed. However, changes in intracellular signal
transduction pathways are almost certainly involved. Pemphigus
IgG is now known to activate a number of signalling pathways
including the Fas/Fas ligand cell death pathway [81] and the
mitogen activated protein (MAP)-kinase pathway [82]. Pem-
phigus IgG also induces phospholipase C activation, inositol
1,4,5-triphosphate generation, increases in intracellular calcium
concentration and a redistribution of PKC from cytosolic to
cytoskeletal fractions within the cell [83–85]. Moreover, it
interferes with RhoA signalling [86]. Antigens other than
desmogleins may be important. Antibodies against cholinergic
receptors have been detected in pemphigus patients [87] and
cholinergic agonists prevent PV IgG-induced blistering in a
mouse model for the disease [88]. In contrast to anti-desmoglein
antibodies, antibodies against cholinergic receptors are unable to
trigger blister formation in the mouse model on their own but
they do act synergistically with anti-desmoglein antibodies [89].
Loss of desmosomal adhesion, and skin blistering, occurs in
bullous impetigo and staphylococcal scalded skin syndrome
[76]. These are localised and more generalised forms of the same
disease that is caused by Staphylococcus aureus infections. The
bacterium releases toxins with serine protease activity that
specifically cleave Dsg1 [90]. Netherton syndrome is another
disease that almost certainly results from abnormal cleavage of
desmosomal cadherins. Patients do not develop blisters such as
those that occur in pemphigus and staphylococcal scalded skin
syndrome but instead exhibit dry, scaly skin (ichthyosis), hairshaft abnormalities and atopic manifestations. Abnormalities
in the epidermis include altered desquamation and impaired
keratinisation. Netherton syndrome is caused by autosomal re-
cessive mutations in the SPINK5 gene that encodes the serine
protease lympho-epithelial Kazal-type-related inhibitor LEKTI
[91]. LEKTI inhibits trypsin- and chymotrypsin-like protease
activity [92], and it is thought that premature cleavage of
corneodesmosmal proteins (including Dsc1, Dsg1 and corneo-
desmosin) and subsequent corneodesmosome disruption in the
upper epidermis is responsible for the disease [19,93,94].
3.2. Abnormalities in tissue differentiation and morphogenesis
occur in some diseases of desmosomes
In many diseases of desmosomes it is difficult to ascribe
all aspects of phenotype to defective cell adhesion. Striate
palmoplanter keratoderma is an autosomal dominant disease
that can be caused by haploinsufficiency in the gene encoding
Dsg1 [95]. Patients exhibit thickening of the epidermis of the
palms of hands and soles of feet. Epidermal thickening is a
common response to skin barrier defects and it is may be that the
causative factor is a reduction in cell adhesion. However, as we
have seen in pemphigus desmogleins are able to transduce
signals across the membrane and it may be that abnormal
desmoglein ratios in the skin of patients affects proliferation/
differentiation. Loss of either Dsc1 [96], Dsg3 [97] or Dsg4 [98]
in mice produces blistering phenotypes due to loss of adhesion.
In the case of Dsc1 and Dsg4 blistering is accompanied by
increased proliferation and alterations in differentiation. Wheth-
er these changes are the result of defective adhesion (and sub-
sequent skin barrier defects) or are a consequence of altered
desmosomal cadherin ratios in the epidermis is uncertain.
However skin barrier defects in neonatal Dsc1 null mice are
highly localised whereas hyperproliferation and alterations in
differentiation are found throughout the epidermis, suggesting
that the latter may be the case [96]. Autosomal dominant striate
palmoplantar keratoderma can also be caused by desmoplakin
insufficiency [99,100].
Further support for the idea that altered desmosomal cadherin
ratios in the epidermis can affect proliferation/differentiation has
been obtained in misexpression experiments with genetically
altered mice. In normal epidermis Dsg3 and Dsc3 are most
strongly expressed in lower layers whereas Dsg2 is exclusively
expressed in the basal layer (Fig. 2). Misexpression of either
Dsg3 or Dsc3 in suprabasal layers of the epidermis, driven by the
keratin 1 promoter, results in increased cell proliferation and
altered differentiation [101,102]. Suprabasal Dsg2 expression,
driven by the involucrin promoter, has similar effects [103]. No
barrier defects were detected in these animals. Misexpression of
Dsg3 driven by the involucrin promoter (as opposed to the
keratin 1 promoter in [101]) also results in altered differentiation,
but in this experiment abnormalities in the morphology of the
stratum corneum and barrier defects were observed, causing
increased water permeability and death from dehydration soon
after birth [104]. Misexpression of desmosomal cadherins in
suprabasal layers of the skin clearly has dramatic effects on
phenotype. By contrast, misexpression of either Dsc1 of Dsg1,
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in the basal layer (using the keratin 14 promoter) has no effect on
the skin [105,106].
In the autosomal recessive disease ectodermal dysplasia/skin
fragility syndrome (caused by mutations in PKP1) cutaneous
blistering and erosions almost certainly occur as a result of result
of defective adhesion. However, abnormalities in hair, nails and
sweat glands may be due to altered morphogenesis of the
ectoderm during development [3]. Autosomal recessive muta-
tions in plakoglobin [107] and desmoplakin [108] cause Naxos
disease, which is characterised by palmoplantar keratoderma,
woolly hair and arrhythmogenic right ventricular cardiomyop-
athy (ARVC). Autosomal recessive mutations in desmoplakin
also cause a variant of Naxos disease (Carvajal syndrome) with
palmoplantar keratoderma, woolly hair and generalised dilated
cardiomyopathy [109]. In Naxos disease and Carjaval syndrome
defective cell adhesion could be responsible for the palmoplantar
keratoderma although it is possible that desmosomal cadherins
(and other desmosomal constituents) regulate proliferation and
differentiation independently of their role of adhesion molecules
(see above). Similarly, woolly hair could be a manifestation of
weakened cell adhesion in the hair follicle or as a result of altered
patterns of hair follicle differentiation. ARVC is characterised by
gradual loss of myocytes and replacement by fatty and fibrous
tissue. Again, the question arises as to whether ARVC is caused
by defective adhesion or alterations in differentiation and mor-
phogenesis. Impaired desmosomal adhesion could lead to cell
detachment and death of cardiomyocytes, followed by inflam-
mation and fibrofatty replacement. However, a recent study has
shown suppression of desmoplakin expression in a cardiac
myocyte cell line leads a reduction in Wnt/β-catenin signalling
(see below) and this is accompanied by increased expression
of adipogenic and fibrogenic genes and accumulation of fat
droplets [110]. This shows that alterations in the expression of
desmosomal constituents can have radical effects on the charac-
teristics and behaviour of cells through alterations in intracel-
lular signalling (as discussed below). It is of note that mutations
in Dsc2 [111,112], Dsg2 [113,114], PKP2 [115] and desmopla-
kin [116] are now known to cause AVRC, but without skin and
hair involvement. Thus mutations in all major desmosomal
components can give rise to ARVC. Whether all of these muta-
tions give rise to similar signalling defects, or indeed whether a
mechanical explanation such as weakened adhesion is ultimately
responsible for the phenotype in some or all of these cases
remains to be seen.
Do desmosomes contribute to the generation of epithelial
architecture during morphogenesis, as well as potentially being
involved in regulation of proliferation and differentiation? It
has long been accepted that differential expression of classical
cadherins induces sorting out of mixed cell populations (see
[117]). One example where desmosomes could have a similar
function has been described. The alveoli of the mammary gland
are spherical structures that consist of a layer of epithelial cells
that line the lumen and a layer of underlying myoepithelial cells
that separate the luminal cells from the underlying basement
membrane. Luminal cell secretes milk into the lumen and myo-
epithelial cells are able to contract and so force milk out of thealveoli. Of the desmosomal cadherins luminal epithelial cells
express desmocollins 2 and 3 and desmogleins 2 and 3, whereas
myoepithelial cells express only Dsc3 and Dsg3. Significantly,
luminal and myoepithelial cells sort out in rotary culture to form
aggregates that resemble alveolar structures found in vivo.
Moreover, aggregation is inhibited by short function blocking
peptides that correspond to the CAR sites (Fig. 3) of desmocollin
and desmoglein [62]. This experiment provides good evidence
that desmosomal cadherins may regulate cell positioning during
morphogenesis.
3.3. Desmosomes can influence intracellular signal
transduction pathways
If desmosomal cadherins are involved in regulating prolifer-
ation and differentiation they may do so by influencing intra-
cellular signal transduction pathways. They could achieve this
by regulating the availability of signalling molecules, plakoglo-
bin being a prime candidate. For example, in the epidermis the
availability of plakoglobin could be reduced as keratinocytes
differentiate because Dsg1 may have greater plakoglobin bind-
ing potential than do the other desmogleins [118]. It is now
generally accepted that plakoglobin has a role in the Wnt/β-
catenin signalling pathway. It is closely related to β-catenin, a
key player in the pathway, and both interact with many of the
same molecules [119]. In the canonical Wnt/β-catenin pathway,
cytoplasmic β-catenin is degraded in the absence of a Wnt
signal. However, in the presence of Wnts β-catenin degradation
is blocked, it accumulates in the cytoplasm and is then able to
translocate to the nucleus where it converts T-cell factor (Tcf)/
lymphoid enhancer factor (Lef) family DNA binding proteins
into transcriptional activators (for more details see [120]).
Plakoglobin is also able to interact with Tcf/Lef proteins, but it is
not yet clear whether it activates or represses Wnt/β-catenin
target genes or indeed whether it acts on a distinct set of genes.
There are several ways that plakoglobin could stimulate
transcription of Wnt/β-catenin target genes. Firstly, it could
translocate to the nucleus and act as a transcription coactivator in
its own right. Thus, plakoglobin is a strong activator of the c-myc
promoter [121]. β-Catenin is also able to activate c-myc
expression, but only weakly, implying that the two armadillo
proteins may have differential effects on target genes. Secondly,
it could block cytoplasmic degradation of β-catenin so allowing
β-catenin to translocate to the nucleus. This may be one explan-
ation for the finding that cytoplasmically anchored plakoglobin
is able to mimic the effect of free β-catenin and induce axis
duplication in the early Xenopus embryo [122]. Thirdly, it could
displace β-catenin from adherens junctions and so allow the
latter to translocate to the nucleus. This could explain how loss of
Dsc1 in the epidermis of null mice causes a redistribution of β-
catenin from the membrane to the nucleus (and is accompanied
by enhanced Wnt/β-catenin signalling) (Merritt, A.J., Hardman,
M.J., Aldren, N.L., Chidgey, M.A. and Garrod, D.R., unpub-
lished data). Paradoxically, nuclear localisation and increased
signalling also occur when Dsc3 is overexpressed in the upper
layers of the epidermis in transgenic mice [102]. Other desmo-
somal constituents could be involved in the pathway; over-
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activity in cultured cells [73].
Some evidence suggests that plakoglobin can inhibit the
transcription of Wnt/β-catenin-responsive genes. Tcf-4 com-
plexes containing plakoglobin do not bind DNA [123] so it may
be that plakoglobin is able to block β-catenin-mediated activ-
ation of this and perhaps other Tcfs. Release of plakoglobin from
desmosomes by suppression of desmoplakin expression in
cardiac myocytes (using small interfering RNA) leads to nuclear
localisation of plakoglobin and suppression of Wnt/β-catenin
signalling [110]. Similarly, in keratinocytes nuclear translo-
cation of both plakoglobin and β-catenin following treatment
with the tyrosine phosphatase inhibitor peroxovanadate results
in down-regulation of transcription from Tcf/Lef reporter cons-
tructs [124].
Other pathways are also affected by altered patterns of
desmosomal cadherin expression in the epidermis. Suprabasal
expression of Dsg2 in transgenic mouse skin results in enhanced
activation of the phosphatidylinositol 3-kinase, MAP-kinase,
STAT3 and NFκB pathways [103]. A novel signalling activity
of p0071 has recently been described. It now appears that, in
common with its close relative p120-catenin, p0071 is able to
regulate Rho GTPase activity. Both knockdown and over-
expression of p0071 interfere with normal growth and sur-
vival of cultured cells due to cytokinesis defects. The failure of
cytokinesis correlates with deregulation of Rho activity, an
effect that is mediated by interaction of p0071 with Ect2, a Rho
guanine–nucleotide exchange factor essential for cytokine-
sis [40]. It is by no means certain that this signalling function, or
indeed those ascribed to plakoglobin and plakophilins, is in
any way connected to the presence of p0071 in desmosomes
but nevertheless the possibility that it is remains an exciting one.
3.4. Desmosomes in embryonic development
In the early mouse embryo desmosomes are formed for the
first time at embryonic day of development 3.5 (E3.5) in the
trophectoderm, a layer of cells that surrounds the inner cell mass
[125]. Interestingly, Dsc3 null embryos die (at about E2.5)
before desmosomes appear and it may be that Dsc3 has an extra-
desmosomal function and is required for adhesion of cells
(blastomeres) in the early embryo [126]. Dsg2−/− embryos die
later, at around implantation at E4.5 [127]. Dsg2, in common
with Dsc3, could have an extra-desmosomal function. A clue as
to this function was obtained when blastocysts from intercrosses
of Dsg3 heterozygous +/− mice were placed in culture with
feeder cells. Under these conditions embryos hatch and the cells
of the inner cell mass (which do not produce desmosomes) form
outgrowths. Although it was possible to establish cultures of
−/− cells the cells died after a limited period, suggesting that
Dsg2 could have a role in embryonic stem cell proliferation
[127]. Desmoplakin null embryos survive implantation but die
at E6.5 [128]. The most likely cause of death is a defect in cell
adhesion during egg cylinder elongation, but it is of note that
cell proliferation is also impaired in these animals.
Plakoglobin null animals usually die at around mid-gestation
(E10.5) as a result of heart defects. Occasionally some animalssurvive until late gestation and exhibit an additional skin
blistering phenotype [28,129]. PKP2 null mice also die in mid-
gestation, again due to heart defects [130]. Hearts from both
plakoglobin and PKP2−/− animals show morphological abnor-
malities including reduced thickness of atrial walls and reduced
trabeculation of ventricles. These abnormalities in morphology
may be responsible for the catastrophic problems, including
rupture of cardiac walls and blood leakage into the pericardial
cavity, that occur at the onset of heart contraction when the
developing heart is first subjected to significant mechanical
stress. Thus, alterations in morphogenesis coupled with weak-
ened cardiomyocyte adhesion, are the probable cause of death in
these animals. Plakoglobin and PKP2 null animals survive
much longer than their desmoplakin counterparts. There may be
a number of reasons for this. In plakoglobin null animals β-
catenin may be able to partially substitute for plakoglobin
function [131] and desmoplakin could bypass plakoglobin ad-
hesive function in plakoglobin−/− mice by interacting directly
with desmosomal cadherins [67,71]. Plakophilins could add
strength to desmosomes by engaging in lateral interactions [72]
but these may be superfluous until the heart begins beating and
is placed under severe mechanical stress.
4. Conclusion
Hyper-adhesion is a unique feature of desmosomes that
enables them to provide a strong link in the chain that makes
up the DIFC complex. This strong link is required to resist
mechanical stress but importantly it appears that hyper-
adhesiveness can be modulated. Thus signalling by PKC allows
hyper-adhesiveness to be reduced in embryogenesis and wound
healing facilitating morphogenetic movement and tissue repair.
Structural and biophysical studies are now required to define the
mechanisms of desmosomal adhesion, and more detailed
studies are required to address the role of PKC and other
kinases in regulating adhesiveness. It now appears clear that
desmosomes have an important role in regulating crucial
aspects of cell behaviour such as cell proliferation and differ-
entiation. Further research to define the signalling capacity of
desmosomes and to specify the down-stream consequences of
their signalling activity will be of great benefit to our under-
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